Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44347 clinical trials with a EudraCT protocol, of which 7375 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,347)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,347 result(s) found. Displaying page 313 of 2,218.

EudraCT Number: 2009-010423-58

Sponsor Protocol Number: KF5503/42

Start Date*: 2009-08-28

Sponsor Name:Grünenthal GmbH

Full Title: An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chr...

Medical condition: Pain due to Osteoarthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10031161	Osteoarthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) ES (Completed) DE (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2008-006921-14

Sponsor Protocol Number: AF-H-01

Start Date*: 2009-02-09

Sponsor Name:ALK-Abelló Arzneimittel GmbH

Full Title: A multicentre randomised Phase II clinical trial to demonstrate equivalent pharmacodynamic efficacy and tolerability of two updosing schedules for ALK-Flex SQ

Medical condition: Grass pollen induced allergic rhinoconjunctivitis requiring treatment during the grass pollen season

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10001728	Allergic rhinoconjunctivitis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-006931-11

Sponsor Protocol Number: CPKC412A2114

Start Date*: 2009-11-09

Sponsor Name:Novartis Pharma Services AG

Full Title: A phase I/II, open-label, dose-escalating study to evaluate the safety, tolerability and pharmacokinetics of twice daily oral midostaurin and to evaluate the preliminary clinical and pharmacodynami...

Medical condition: in pediatric patients with relapsed or refractory leukemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10000835	Acute leukemia	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Completed) SE (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2008-006937-28

Sponsor Protocol Number: OPHT-040908

Start Date*: 2009-03-30

Sponsor Name:Universitätsklinik für Klinische Pharmakologie

Full Title: Effect of Rosuvastatin on endothelial function in patients with diabetes and glaucoma

Medical condition: volunteers with Diabetes type I or II and volunteers with Glaucoma are included Glaucoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10012602	Diabetes mellitus (incl subtypes)	HLT
	9.1		10018305	Glaucomas (excl congenital)	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2008-000640-14

Sponsor Protocol Number: 1245.9

Start Date*: Information not available in EudraCT

Sponsor Name:Boehringer ingelheim Pharma GmbH & Co KG

Full Title: A Phase IIb, randomized, parallel group safety, efficacy, and pharmacokinetics study of BI 10773 (5mg, 10mg and 25mg) administered orally once daily over 12 weeks compared double blind to placebo, ...

Medical condition: Type 2 Diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SE (Completed) IT (Completed) EE (Completed) LT (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2006-006523-40

Sponsor Protocol Number: ML20944

Start Date*: 2007-04-13

Sponsor Name:Roche AB

Full Title: A single arm open label study to assess the efficacy, safety and tolerability and of once-monthly administration of subcutaneous C.E.R.A. for the maintenance of haemoglobin levels in pre-dialysis p...

Medical condition: Chronic renal anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10058116	Nephrogenic anaemia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2007-002457-24

Sponsor Protocol Number: 1218.17

Start Date*: 2008-01-24

Sponsor Name:Boehringer Ingelheim Finland Ky

Full Title: A randomised, double-blind, placebo-controlled parallel group efficacy and safety study of BI 1356 (5 mg administered orally once daily) over 24 weeks in type 2 diabetic patients with insufficient ...

Medical condition: Type 2 diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) SE (Completed) CZ (Completed) GR (Completed)

Trial results: View results

EudraCT Number: 2007-004879-19

Sponsor Protocol Number: 0476-377

Start Date*: 2008-02-08

Sponsor Name:Merck & Co., Inc.

Full Title: A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction (EIB) i...

Medical condition: Exercise Induced Bronchoconstriction (EIB)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10006464	Bronchoconstriction	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: EE (Completed)

Trial results: View results

EudraCT Number: 2007-004897-26

Sponsor Protocol Number: Lu-11829A

Start Date*: 2008-05-23

Sponsor Name:King's College London [...]

Full Title: Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer's disease - MAIN-AD

Medical condition: Alzheimer's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10001896	Alzheimer's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2010-019980-13

Sponsor Protocol Number: A-95-58035-017

Start Date*: 2012-05-14

Sponsor Name:Ipsen Farmaceutica b.v.

Full Title: Predictive value of baseline and stimulated serum IGF-I and IGFBP-3 during a dose-escalation IGF-I generation test with NutropinAq for the 1 year growth response to growth hormone (GH) therapy in s...

Medical condition: Severe idiopathic short stature

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10028395 - Musculoskeletal and connective tissue disorders	10066333	Idiopathic short stature	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-005706-44

Sponsor Protocol Number: TOPO-LAPA/CFB/2007-05

Start Date*: 2008-01-11

Sponsor Name:Centre François Baclesse

Full Title: Etude de phase II évaluant l'association topotécan-lapatinib chez des patientes en rechute moins de 12 mois après une première ligne de chimiothérapie à base de platine pour un cancer de l'ovaire, ...

Medical condition: Patientes atteintes d'un cancer de l'ovaire, ou de la trompe ou du péritoine en rechute moins de 12 mois après une première ligne de chimiothérapie à base de sels de platine.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10066697	Ovarian cancer recurrent	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-011010-23	Sponsor Protocol Number: 2009-10	Start Date*: 2009-12-23
Sponsor Name:Assistance Publique Hopitaux de marseille
Full Title: Evaluation de l’efficacité de l’anesthésie locale lors de la réalisation d’une laryngoscopie indirecte au naso-fibroscope souple en consultation d’ORL pédiatrique.
Medical condition: LARYNGOSCOPIE INDIRECTE AU NASO-FIBROSCOPE
Disease:
Population Age: Children, Under 18		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-007661-24

Sponsor Protocol Number: GLP112754

Start Date*: 2009-07-01

Sponsor Name:GlaxoSmithKline Research and Development Ltd.

Full Title: Estudio multicéntrico, aleatorizado, abierto y de grupos paralelos para determinar la eficacia y la seguridad a largo plazo de la albiglutida en comparación con la insulina en sujetos con diabetes ...

Medical condition: Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-007662-37

Sponsor Protocol Number: GLP112755

Start Date*: 2009-07-01

Sponsor Name:GlaxoSmithKline Research and Development Ltd.

Full Title: Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para determinar la eficacia y la seguridad de la albiglutida administrada en combinación con pioglitaz...

Medical condition: Diabetes mellitus de tipo 2 Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2009-013063-19

Sponsor Protocol Number: HZC102871

Start Date*: 2010-06-28

Sponsor Name:GlaxoSmithKline Research & Development

Full Title: A 52-week efficacy and safety study to compare the effect of three dosage strengths of Fluticasone Furoate/GW642444 Inhalation Powder with GW642444 on the Annual Rate of Exacerbations in Subjects w...

Medical condition: Patients with Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SE (Completed) GB (Completed) IT (Completed) NL (Completed) EE (Completed)

Trial results: View results

EudraCT Number: 2009-013065-25

Sponsor Protocol Number: HZC112206

Start Date*: 2010-04-26

Sponsor Name:GlaxoSmithKline Research & Development Ltd

Full Title: A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Com...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10009033	Chronic obstructive pulmonary disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) EE (Completed)

Trial results: View results

EudraCT Number: 2009-015742-34	Sponsor Protocol Number: APIDR_L_04717	Start Date*: 2009-12-11
Sponsor Name:sanofi-aventis
Full Title: Better Accepance of a Singe injection Apidra (insulin glulisine) Added to once daily Lantus (insulin glargine) versus twice daily Premixed insulin in a real Life Use Setting.
Medical condition: Type 2 Diabetes Mellitus
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: View results

EudraCT Number: 2006-001514-33

Sponsor Protocol Number: BUSAL-III-05-1

Start Date*: 2006-06-05

Sponsor Name:Laboratories SMB S.A.

Full Title: A phase III, randomized, parallel group study to compare the therapeutic efficacy of SMB BUDESONIDE-SALMETEROL DPI capsule 300/25μg BID delivered by the AXAHALER® versus SERETIDE® DISKUS® 500/50μg ...

Medical condition: Diagnosis of moderate to severe persistent asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.0		10003553		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) EE (Completed)

Trial results: View results

EudraCT Number: 2009-011279-56

Sponsor Protocol Number: IBU/20mg/2009

Start Date*: 2009-07-31

Sponsor Name:Orphan Europe Recordati

Full Title: Multicenter open-label pilot study to evaluate the safety, pharmacology and efficacy of a new dose regimen (i.e. 20-10-10 mg/kg) of Pedea (intravenous ibuprofen) in preterm newborn infants of less ...

Medical condition: Hemodynamically significant persisting ductus arteriosus in preterm infants of less than 28 weeks of gestational age

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10034130	Patent ductus arteriosus	LLT

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2009-011423-31

Sponsor Protocol Number: noneX

Start Date*: 2009-09-04

Sponsor Name:CENTRE JEAN PERRIN

Full Title: Essai pilote de phase II évaluant l'association Taxotère® plus curcumine en première ligne de traitement des cancers de la prostate métastatiques hormono-résistants

Medical condition: cancers de la prostate métastatiques hormono-résistants

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10036909	Prostate cancer metastatic	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: FR (Completed)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Jul 08 07:17:03 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA